UB Paderborn / Katalog / Suche / in CDI

Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV‐infected patients on antiretroviral therapy in sub‐Saharan Africa

Tropical medicine & international health, 2015-05, Vol.20 (5), p.569-580

2015

Volltextzugriff (PDF)

High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy

Clinical infectious diseases, 2014-04, Vol.58 (7), p.1023-1026

2014

Volltextzugriff (PDF)

Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa

Journal of antimicrobial chemotherapy, 2017-05, Vol.72 (5), p.1450-1455

2017

Volltextzugriff (PDF)

The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural Models

American journal of epidemiology, 2015-10, Vol.182 (7), p.633-643

2015

Volltextzugriff (PDF)

Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa

AIDS (London), 2006-06, Vol.20 (10), p.1391-1399

Walker, A S

2006

Volltextzugriff (PDF)

Lopinavir/Ritonavir Monotherapy after 24 Weeks of Second-Line Antiretroviral Therapy in Africa: A Randomized Controlled Trial (Sara)

Antiviral therapy, 2012-01, Vol.17 (7), p.1363-1373

2012

Volltextzugriff (PDF)

Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells/μl

AIDS (London), 2008-01, Vol.22 (2), p.237-247

Anon

2008

Volltextzugriff (PDF)

Viral Rebound and Emergence of Drug Resistance in the Absence of Viral Load Testing: A Randomized Comparison between Zidovudine-Lamivudine plus Nevirapine and Zidovudine-Lamivudine plus Abacavir

The Journal of infectious diseases, 2010-01, Vol.201 (1), p.106-113

2010

Volltextzugriff (PDF)

Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda

Journal of antimicrobial chemotherapy, 2014-07, Vol.69 (7), p.1938-1944

2014

Volltextzugriff (PDF)

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe

Journal of acquired immune deficiency syndromes (1999), 2008-08, Vol.48 (4), p.468

2008

Volltextzugriff (PDF)

Distribution of HLA‐B alleles in a Ugandan HIV‐infected adult population: NORA pharmacogenetic substudy of DART

Tropical medicine & international health, 2011-02, Vol.16 (2), p.200-204

2011

Volltextzugriff (PDF)

Pharmacokinetics of Lopinavir-Ritonavir with and without Nonnucleoside Reverse Transcriptase Inhibitors in Ugandan HIV-Infected Adults

Antimicrobial Agents and Chemotherapy, 2010-07, Vol.54 (7), p.2965-2973

2010

Volltextzugriff (PDF)

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48‐week randomized comparison with abacavir/zidovudine/lamivudine in HIV‐infected Ugandan adults with low CD4 cell counts

HIV medicine, 2010-05, Vol.11 (5), p.334-344

2010

Volltextzugriff (PDF)

Twenty‐four‐week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine/lamivudine as first‐line antiretroviral therapy: a randomized double‐blind trial (NORA)

Tropical medicine & international health, 2008-01, Vol.13 (1), p.6-16

2008

Volltextzugriff (PDF)

Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California

Science (American Association for the Advancement of Science), 2020-07, Vol.369 (6503), p.582-587

2020

Volltextzugriff (PDF)

Alcohol-Related Physical Abuse of Children in the Slums of Kampala, Uganda

International journal of environmental research and public health, 2017-09, Vol.14 (10), p.1124

2017

Volltextzugriff (PDF)

O-08: NEUROCOGNITIVE IMPAIRMENT IN UGANDAN CHILDREN WITH SICKLE CELL ANEMIA COMPARED TO NON-SICKLE SIBLINGS

HemaSphere, 2022-08, Vol.6 (Suppl), p.5-6

2022

Volltextzugriff (PDF)

POS-087 MINERAL BONE DISORDERS IN CHILDREN WITH SICKLE CELL ANEMIA AND ACUTE KIDNEY INJURY

Kidney international reports, 2022-02, Vol.7 (2), p.S36-S36

2022

Volltextzugriff (PDF)

Malaria parasitemia among blood donors in Uganda

Transfusion (Philadelphia, Pa.), 2020-05, Vol.60 (5), p.955-964

2020

Volltextzugriff (PDF)

O‐08: NEUROCOGNITIVE IMPAIRMENT IN UGANDAN CHILDREN WITH SICKLE CELL ANEMIA COMPARED TO NON‐SICKLE SIBLINGS

HemaSphere, 2022-08, Vol.6, p.05-06

2022

Volltextzugriff (PDF)

Pharmacokinetics of Antiretroviral Drug Varies With Formulation in the Target Population of Children With HIV-1

Clinical pharmacology and therapeutics, 2012-02, Vol.91 (2), p.272-280

2012

Volltextzugriff (PDF)

Transfusion Medicine in Sub-Saharan Africa: Conference Summary

Transfusion medicine reviews, 2015-07, Vol.29 (3), p.195-204

2015

Volltextzugriff (PDF)

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe

PloS one, 2012-04, Vol.7 (4), p.e33672

2012

Volltextzugriff (PDF)

Correlates of suicide ideation and attempt among youth living in the slums of Kampala

International journal of environmental research and public health, 2012-02, Vol.9 (2), p.596-609

2012

Volltextzugriff (PDF)

Apical Hypertrophic Cardiomyopathy Presenting as Recurrent Unexplained Syncope

Clinical medicine & research, 2012-02, Vol.10 (1), p.26-31

2012

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV‐infected patients on antiretroviral therapy in sub‐Saharan Africa

High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy

Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa

The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural Models

Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa

Lopinavir/Ritonavir Monotherapy after 24 Weeks of Second-Line Antiretroviral Therapy in Africa: A Randomized Controlled Trial (Sara)

Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells/μl

Viral Rebound and Emergence of Drug Resistance in the Absence of Viral Load Testing: A Randomized Comparison between Zidovudine-Lamivudine plus Nevirapine and Zidovudine-Lamivudine plus Abacavir

Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe

Distribution of HLA‐B alleles in a Ugandan HIV‐infected adult population: NORA pharmacogenetic substudy of DART

Pharmacokinetics of Lopinavir-Ritonavir with and without Nonnucleoside Reverse Transcriptase Inhibitors in Ugandan HIV-Infected Adults

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48‐week randomized comparison with abacavir/zidovudine/lamivudine in HIV‐infected Ugandan adults with low CD4 cell counts

Twenty‐four‐week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine/lamivudine as first‐line antiretroviral therapy: a randomized double‐blind trial (NORA)

Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California

Alcohol-Related Physical Abuse of Children in the Slums of Kampala, Uganda

O-08: NEUROCOGNITIVE IMPAIRMENT IN UGANDAN CHILDREN WITH SICKLE CELL ANEMIA COMPARED TO NON-SICKLE SIBLINGS

POS-087 MINERAL BONE DISORDERS IN CHILDREN WITH SICKLE CELL ANEMIA AND ACUTE KIDNEY INJURY

Malaria parasitemia among blood donors in Uganda

O‐08: NEUROCOGNITIVE IMPAIRMENT IN UGANDAN CHILDREN WITH SICKLE CELL ANEMIA COMPARED TO NON‐SICKLE SIBLINGS

Pharmacokinetics of Antiretroviral Drug Varies With Formulation in the Target Population of Children With HIV-1

Transfusion Medicine in Sub-Saharan Africa: Conference Summary

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe

Correlates of suicide ideation and attempt among youth living in the slums of Kampala

Apical Hypertrophic Cardiomyopathy Presenting as Recurrent Unexplained Syncope

Suchergebnisse filtern